A 12‐week study to evaluate the 24 hour pulmonary function of fluticasone furoate (FF)/vilanterol inhalation powder (FF/VI inhalation powder) once daily compared with salmeterol/fluticasone propionate (FP) inhalation powder twice daily in subjects with chronic obstructive pulmonary disease (COPD)

Authors
Category Primary study
Year 2013
This article has no abstract
Epistemonikos ID: 8104df72be098e378a11c135760ddd611bdc82ce
First added on: Sep 03, 2019